GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » Transphorm Inc (NAS:TGAN) » Definitions » Cash, Cash Equivalents, Marketable Securities

Transphorm (Transphorm) Cash, Cash Equivalents, Marketable Securities : $7.95 Mil (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Transphorm Cash, Cash Equivalents, Marketable Securities?

Transphorm's quarterly cash, cash equivalents, marketable securities increased from Jun. 2023 ($3.31 Mil) to Sep. 2023 ($6.15 Mil) and increased from Sep. 2023 ($6.15 Mil) to Dec. 2023 ($7.95 Mil).

Transphorm's annual cash, cash equivalents, marketable securities increased from Dec. 2020 ($14.69 Mil) to Mar. 2022 ($33.44 Mil) but then declined from Mar. 2022 ($33.44 Mil) to Mar. 2023 ($15.53 Mil).


Transphorm Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Transphorm's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transphorm Cash, Cash Equivalents, Marketable Securities Chart

Transphorm Annual Data
Trend Dec19 Dec20 Mar22 Mar23
Cash, Cash Equivalents, Marketable Securities
2.88 14.69 33.44 15.53

Transphorm Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.15 15.53 3.31 6.15 7.95

Transphorm Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Transphorm  (NAS:TGAN) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Transphorm Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Transphorm's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Transphorm (Transphorm) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » Transphorm Inc (NAS:TGAN) » Definitions » Cash, Cash Equivalents, Marketable Securities
Traded in Other Exchanges
N/A
Address
75 Castilian Drive, Goleta, CA, USA, 93117
Transphorm Inc is a semiconductor company. It designs and manufactures GaN semiconductors for high-voltage power conversion applications. It produces JEDEC and AEC-Q101-qualified GaN FETs. Its vertically integrated device business model allows for innovation at every development stage: design, fabrication, device, and application support.
Executives
Kelly Smales director 75 CASTILIAN DRIVE, GOLETA CA 93117
Katharina G. Mcfarland director 4803 STONECROFT BOULEVARD, CHANTILLY VA 20151
Kkr Phorm Investors L.p. 10 percent owner C/O KOHLBERG KRAVIS ROBERTS & CO. L.P., 30 HUDSON YARDS, NEW YORK NY 10001
Primit Parikh officer: Chief Operating Officer 75 CASTILIAN DRIVE, GOLETA CA 93117
Cameron Mcaulay officer: Chief Financial Officer 75 CASTILIAN DRIVE, GOLETA CA 93117
Umesh Mishra director, officer: Chief Technology Officer 75 CASTILIAN DRIVE, GOLETA CA 93117
Mario Rivas director, officer: Chief Executive Officer 141 MT. BETHEL ROAD, WARREN NJ 07059
Kkr Group Co. Inc. 10 percent owner 30 HUDSON YARDS, NEW YORK NY 10001
Cynthia J Moreland director 215 MOFFETT PARK DRIVE, SUNNYVALE CA 94089
Michael Julian Humphreys director 75 CASTILIAN DRIVE, GOLETA CA 93117
Brittany Bagley director C/O SONOS, INC., 614 CHAPALA STREET, SANTA BARBARA CA 93101
David M Kerko director C/O KKR, 9 WEST 57TH STREET, 41ST FLOOR, NEW YORK NY 10019
Kkr Group Holdings Corp. 10 percent owner C/O KOHLBERG KRAVIS ROBERTS & CO. L.P., 30 HUDSON YARDS, NEW YORK NY 10001
Kkr Group Partnership L.p. 10 percent owner C/O KOHLBERG KRAVIS ROBERTS & CO. L.P., 30 HUDSON YARDS, NEW YORK NY 10001
Eiji Yatagawa director 75 CASTILIAN DRIVE, GOLETA CA 93117